Drugmaker Bristol-Myers Squibb Co., which will report third-quarter results before the stock market opens Thursday, likely will focus on early sales of three recently approved drugs, trends for top seller Plavix as generic competition looms and an update of its research.
Popular Posts:
- Earnings roundup: Amerigroup, Pepco
- Earnings roundup: Amerigroup, Pepco
- Earnings roundup: SandRidge Energy, PharMerica
- Earnings schedule for week of 11/1/10
- Aetna lifts earnings outlook for 2011, 2012